NIH-funded research R01 grant

How calorie restriction may reduce blood clot risks in older adults

Official title: Preventive mechanisms of Age-associated Thrombosis

Funded at University of Iowa · NIH-11003368 · Data updated 2026-11-12

This study is looking at how eating fewer calories might help older adults with type 2 diabetes lower their chances of developing blood clots, which can lead to serious heart problems.

More Thrombosis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Iowa
NIH-funded
Lab location1 site (Iowa City, United States)
Project startJanuary 1, 2024
Project endDecember 31, 2027
Funding year2025
Award (this year)$558,382
NIH project number5R01HL168630-02
Project IDNIH-11003368 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults, especially those with type 2 diabetes or other age-related conditions that increase clotting risks.

Less likely to help

Patients who are younger and do not have any risk factors for thrombosis or age-related conditions may not benefit from this research.

What this research studies

This research investigates the effects of calorie restriction on reducing the risk of blood clots in older adults, particularly those with type 2 diabetes. By studying aged mice, the researchers aim to understand how calorie restriction can diminish prothrombotic effects linked to aging and identify potential drug targets. The study focuses on the role of mitochondrial function and oxidative stress in platelet activation, which contributes to increased clotting risks. The findings could lead to new strategies for preventing serious cardiovascular events in the elderly.

Why it matters

Potential benefit: If successful, this research could lead to new preventive measures against life-threatening blood clots in older adults.

How similar studies have gone: Previous research has shown promising results in using calorie restriction and mitochondrial-targeted therapies to reduce thrombotic risks, indicating a potential for success in this approach.

Where this research is happening

  • University of Iowa
    Iowa City, United States
    Active

Researchers

  • Principal investigator: Dayal, Sanjana — University of Iowa
  • Study coordinator: Dayal, Sanjana

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.